FOSUN PHARMA INDUSTRIAL PTE. LTD. : DISCLOSURES UNDER REGULATION 29(2) OF SEBI (SUBSTANTIAL ACQUISITION OF SHARES AND TAKEOVERS) REGULATIONS, 2011

• Fosun Pharma Industrial Pte. Ltd. disclosed sale of equity shares of Gland Pharma Limited. • Before the sale, the holding was 8,53,93,894 shares (51.76% of total share capital). • Shares acquired/sold were 98,97,000 (6.00% of total share capital). • After the sale, the holding is 7,54,96,894 shares (45.76% of total share capital). • Mode of acquisition/sale was Open Market. • Date of acquisition/sale of shares was September 4, 2026. • Equity share capital of TC before sale was 164,966,661 shares of ₹1 each. • Equity share capital of TC after sale was 164,966,661 shares of ₹1 each. • Total diluted share/voting capital of TC after the said acquisition/sale was 166,262,312 shares of ₹1 each.

Gland Pharma Ltd

Open attachment

← Back to feed